Olive Lifesciences Private Limited

Manufacturer and supplier of nutraceutical products and herbal formulations with ISO 9001 certification.

2007 | Bangaluru, Karnataka (India) | Active
Last Updated: February 05, 2025

Olive Lifesciences Profile

Key Indicators

  • Authorised Capital ₹ 58.95 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 17 Year, 5 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 47.50 Cr
  • Satisfied Charges ₹ 63.51 Cr
  • Revenue Growth 13.58%
  • Profit Growth 33.26%
  • Ebitda 37.74%
  • Net Worth -39.19%
  • Total Assets -9.81%

About Olive Lifesciences

Olive Lifesciences Private Limited (OLPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 18 September 2007 and has a history of 17 years and five months. Its registered office is in Bangaluru, Karnataka, India.

The Company is engaged in the Healthcare Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 58.95 Cr and a paid-up capital of Rs 1.00 Cr.

The company currently has active open charges totaling ₹47.50 Cr. The company has closed loans amounting to ₹63.51 Cr, as per Ministry of Corporate Affairs (MCA) records.

Juie Hilal and Joseph Molath serve as directors at the Company.

Company Details

Corporate Identity Details

  • CIN/LLPIN

    U24230KA2007PTC043892

  • Company No.

    043892

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    18 Sep 2007

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Healthcare

What products or services does Olive Lifesciences Private Limited offer?

Olive Lifesciences Private Limited offers a wide range of products and services, including Inspection & Quality Check Services, Quality Inspection Service, Ayurvedic & Herbal Extracts, Fruit Extracts, Plant Extracts, Ayurvedic Powder and Medicinal Herbs, Herbal Powder.

Who are the key members and board of directors at Olive Lifesciences?

Executive Team (1)

NameDesignationAppointment DateStatus
Joseph Molath Country flag representing In Managing Director17-Jul-2019Current

Board Members (1)

NameDesignationAppointment DateStatus
Juie Hilal Country flag representing In Director 18-Sep-2007Current

Financial Performance of Olive Lifesciences.

Olive Lifesciences Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 13.58% increase. The company also saw a substantial improvement in profitability, with a 33.26% increase in profit. The company's net worth observed a substantial decline by a decrease of 39.19%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
13.58%
Revenue from Operations
15.56%
Total Assets
-9.81%
Profit or Loss
33.26%
Net Worth
-39.19%
EBITDA
37.74%

What is the Ownership and Shareholding Structure of Olive Lifesciences?

Unlock access to Olive Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹47.50 Cr

Satisfied Charges

₹63.51 Cr

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 30.00 Cr
  • Axis Bank Limited : 17.50 Cr

Latest Charge Details

DateLenderAmountStatus
18 Mar 2015Hdfc Bank Limited₹10.00 CrOpen
19 Mar 2014Hdfc Bank Limited₹5.00 CrOpen
02 Jan 2014Hdfc Bank Limited₹15.00 CrOpen
26 Dec 2013Axis Bank Limited₹17.50 CrOpen
02 Jan 2014Hdfc Bank Limited₹15.00 CrSatisfied

How Many Employees Work at Olive Lifesciences?

Olive Lifesciences has a workforce of 32 employees as of Feb 05, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Olive Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olive Lifesciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Olive Lifesciences

Recent activity within the organization

  • Annual General Meeting

    Olive Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Olive Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

    31 Mar 2024

  • Director Appointment

    Joseph Varkey Molath was appointed as a Managing Director was appointed as a Managing Director on 17 Jul 2019 & has been associated with this company since 5 years 7 months .

    17 Jul 2019

  • Charges

    A charge with Axis Bank Limited of Rs. 17.50 Cr registered on 26 Dec 2013 with Charge ID 10470202 was modified on 25 Aug 2016.

    25 Aug 2016

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 10.00 Cr with Charge ID 10558791 was registered on 18 Mar 2015.

    18 Mar 2015

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 5.00 Cr with Charge ID 10501373 was registered on 19 Mar 2014.

    19 Mar 2014

Recent News, Updates & Announcement

Frequently asked questions

  • Olive Lifesciences Private Limited was incorporated on 18 Sep 2007.

  • The authorized share capital of Olive Lifesciences Private Limited is ₹ 58.95 Cr and paid-up capital is ₹ 1.00 Cr.

  • Currently 2 directors are associated with Olive Lifesciences Private Limited.

    • Juie Hilal
    • Joseph Varkey Molath
  • As per Ministry of Corporate Affairs (Mca), the registered address of Olive Lifesciences Private Limited is No. 5805/05 Nh-4 Near Navayuga Toll Gate, Nelamangala India, Bangalore, Karnataka, 562123.

  • The corporate identification number (CIN) of Olive Lifesciences Private Limited is U24230KA2007PTC043892 and the company number is 043892 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Olive Lifesciences Private Limited is https://www.olivelifesciences.com

  • According to the financial reports for the fiscal year 2024, the revenue trend for Olive Lifesciences Private Limited has risen by 13.58%.

  • As Per 2024 financial reports, 32 employees are currently employed by Olive Lifesciences Private Limited.

  • The financial reports for the fiscal year 2024 indicates that The net worth of Olive Lifesciences Private Limited has experienced an downturn of -39.19%.

  • As per the financial statements for fiscal Year 2024, The total open charges for Olive Lifesciences Private Limited amount to ₹ 47.50 Cr.

  • The most recent Balance Sheet for Olive Lifesciences Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Preventive Health Supplements